Kyverna Therapeutics
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
2
Funding Rounds
$110.0m
Money raised
Overview
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
-
Website:
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ju*** Wi**** | - | - | - |
| Ry** Jo*** | - | - | - |
| Gr J. Gi**** | - | - | - |
| Do Bo*** |
|
- | |
| Ja*** Ch*** | - | - | linkedin facebook |
| To* Va* Bl | - | - |
Funding
Funding series
Funding Series Analysis
The company Kyverna Therapeutics has raised a total of $110m in funding over 2 rounds.
Key Insights:
- Kyverna Therapeutics Series B round, January 2022: $85m
- Kyverna Therapeutics Series A round, January 2020: $25m
Kyverna Therapeutics Series B round, January 2022
$85m
Kyverna Therapeutics Series A round, January 2020
$25m
Industries
Kyverna Therapeutics is active in the following industries: